Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2023-09-08 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于2022年限制性股票激励计划第一个解除限售期解除限售条件成就的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from a company regarding the achievement of conditions for the first unlocking period of a 2022 restricted stock incentive plan. It details the number of shares eligible for unlocking, the approval process by the board and shareholders, performance criteria, and legal opinions. It is not a full annual or interim report, nor a financial statement, but rather a formal disclosure about stock incentive plan progress and related share unlocking. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about share incentive plan status and unlocking conditions, not a full report or financial statement.
2023-09-08 Chinese
关于公司开展远期外汇交易业务的可行性分析报告
Management Reports Classification · 95% confidence The document is a detailed feasibility analysis report regarding the company's plan to conduct forward foreign exchange trading to hedge against currency risk. It includes background, purpose, risk analysis, risk control measures, and a conclusion on the necessity and feasibility of the business. The document is issued by the company's board and dated. It is not a financial report like an annual or interim report, nor is it an announcement of voting results or a regulatory filing. It is a management-level report analyzing a specific financial risk management activity. Therefore, it fits best under Management Reports (MDA), which cover management's detailed explanation of business trends and outlook, including risk management strategies.
2023-09-08 Chinese
关于回购注销2022年限制性股票激励计划部分激励对象已获授但尚未解除限售的限制性股票的公告
Transaction in Own Shares Classification · 95% confidence The document is an official announcement from a company regarding the repurchase and cancellation of restricted shares under a 2022 restricted stock incentive plan. It details the number of shares repurchased, the price, the approval process by the board and shareholders, and the impact on the company's share capital structure. It includes legal opinions, independent director opinions, and supervisory board opinions. The document is not a full financial report, earnings release, or management discussion, but rather a specific corporate action announcement related to share repurchase and cancellation of restricted stock. This fits the category of Transaction in Own Shares (POS), which covers company buybacks or cancellations of its own shares.
2023-09-08 Chinese
会计师事务所选聘制度
Governance Information Classification · 95% confidence The document is a detailed internal policy document titled '会计师事务所选聘制度' (Accounting Firm Selection System) for a company, outlining procedures, responsibilities, and requirements for selecting and appointing an accounting firm. It does not contain financial statements, audit results, or financial performance data. It is not an audit report itself but a governance or procedural document related to audit firm selection. It is not an announcement or a brief notice but a formal internal governance document. Therefore, it best fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules and governance practices.
2023-09-08 Chinese
关于第五届董事会第十八次临时会议相关事项的独立董事意见
Board/Management Information Classification · 95% confidence The document is a formal opinion statement from the independent directors of the company regarding specific board meeting matters, including stock incentive plan conditions, stock repurchase and cancellation, and foreign exchange derivative business. It references compliance with regulatory rules and company bylaws, and it is signed by independent directors. The document is not a full financial report, earnings release, or regulatory filing but rather a board/management related announcement expressing independent directors' opinions on board meeting resolutions. The document length is short (1292 characters), and it is not an announcement of a report publication but a substantive opinion document related to board matters. Therefore, the most appropriate classification is Board/Management Information (MANG).
2023-09-08 Chinese
北京国枫律师事务所关于迪瑞医疗科技股份有限公司2021年限制性股票激励计划之回购注销部分限制性股票相关事项的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the repurchase and cancellation of restricted shares under a 2021 restricted stock incentive plan of a company. It details the legal compliance, approvals by the board, supervisory board, and shareholders' meetings, and the specifics of the repurchase price and quantity. It is not a financial report, earnings release, or management discussion, but a legal opinion related to a specific corporate action involving share repurchase and cancellation. This fits best under the category of Regulatory Filings (RNS) as it is a legal compliance document and does not constitute a financial report or announcement of voting results or capital changes by itself. The document length and content confirm it is not a brief announcement but a detailed legal opinion letter, which is typical for RNS filings.
2023-08-23 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.